Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno ...

For example, 2024’s biopharma IPO market began promisingly with $3.6 billion in total funding in Q1 – the highest in several years – but fell to $1.6 billion across Q2 and Q3 combined ...

After hours: February 7 at 5:44:52 PM EST Loading Chart for AYTU ...

Date: September 30, 2024 Total disclosed value: $3.61 billion In September 2024, Bristol Myers Squibb leaned into one of the hottest areas in biopharma with a potential $3.61 billion gene editing cell ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Around 80% of biopharma companies have set net zero or carbon neutrality targets, for example. In addition, 10 of the biggest names have signed up to a renewable energy initiative that aims to ...

Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you. If you’re looking for your next pharma or biotech opportunity, here are the ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.